HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for haemophilia a patients: immune training may restore clotting treatment
Disease control Recruiting nowThis study tests a treatment called immune tolerance induction (ITI) in 300 people with haemophilia A who have developed inhibitors—antibodies that block standard clotting factor therapy. The goal is to retrain the immune system to accept the clotting factor again, using high dos…
Matched conditions: HAEMOPHILIA A
Sponsor: Haemophilia Centre Rhine Main • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New study tracks bleeding disorder treatments in real life
Disease control Recruiting nowThis study looks at how well three clotting factor medicines (Nuwiq, Octanate, Wilate) work in people with severe hemophilia A who have had little or no prior treatment. Researchers will track bleeding events and side effects in 200 patients during routine care. The goal is to un…
Matched conditions: HAEMOPHILIA A
Sponsor: Octapharma • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Breakfast timing could change how hemophilia drug works
Knowledge-focused Recruiting nowThis study tests how eating before and after taking a new medicine called Inno8 affects its absorption in healthy men aged 18-45. Participants will fast overnight, take the drug, and then fast again for different periods. The goal is to find the best meal timing for future use in…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
Iraqi hemophilia patients under the microscope: new study tracks Real-World use of clotting drug
Knowledge-focused Recruiting nowThis study will look back at medical records of 900 male hemophilia A patients in Iraq to see how doctors use the clotting medicine turoctocog alfa in everyday practice. The goal is to understand how often patients have bleeding episodes while on this treatment. No new treatments…
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC